Carl Zeiss Licences Digital Pathology from Olympus

17-Jul-2012

Carl Zeiss Microscopy GmbH and Olympus America Inc. have signed a nonexclusive worldwide licensing agreement allowing Carl Zeiss to access an extensive portfolio of patents held by Olympus in the field of digital pathology and virtual microscopy. The patents included in the licensing deal cover methods and equipment for creating, storing and delivering virtual microscopy slides. The technology enables individuals to view and share high-resolution virtual microscopy images over the Internet.

"The handling of digital data has become a major driver of the development of modern microscopy,” said Dr. Bernhard Ohnesorge, Member of the Board and General Manager BioSciences Division of Carl Zeiss Microscopy. “Integrating the virtual slide functionality into our research microscope systems will enable our customers to become more efficient and to explore new scientific approaches. This will help them to better understand the root causes of the most challenging diseases.”

“Global adoption of digital slide scanning continues to expand into new medical and scientific applications,” said Brad Burklow, Executive Director Business Development, Scientific Equipment Group, Olympus Corporation of the Americas. “Olympus is the holder of many important patents in this area, and we feel it is vital to allow broad access to these technologies in order to advance the field of pathology and medical research. We are confident that leveraging these technologies will enhance healthcare for patients around the world.”

The companies are not making specific terms and conditions of the agreement public.

Facts, background information, dossiers
  • Carl Zeiss
  • Olympus
  • pathology
More about Carl Zeiss
  • News

    New alliance between machine building and IT for Industrie 4.0

    Through the joint venture ADAMOS (ADAptive Manufacturing Open Solutions), DMG MORI, Dürr, Software AG and ZEISS as well as ASM PT are establishing a strategic alliance for the future topics of Industrie 4.0 and the Industrial Internet of Things (IIoT). Germany’s first alliance of well-known ... more

    ZEISS Opts for Continuity: CEO Kaschke confirmed until 2020

    The Supervisory Board of Carl Zeiss AG has decided to continue the appointment of Dr. Michael Kaschke as President & CEO until 30 June 2020. Kaschke joined the ZEISS Group 25 years ago and has served on the Executive Board since 2000. He has been President & CEO of Carl Zeiss AG since 2011. ... more

    ZEISS: Significant Growth in Revenue and Earnings

    The ZEISS Group had a very successful end to the first six months of fiscal year 2016/17 (ended 31 March) and saw its revenue rise by 10 percent to EUR 2.550 billion (1st half of 2015/16: EUR 2.322 billion). At EUR 384 million, the earnings before interest and tax (EBIT) were significantly ... more

More about Olympus
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE